Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Novo’s Obesity Franchise On Track For YE22 But Diabetes Pipeline Steals Show During Q3
As Lilly’s Rival Beats Expectations
Nov 02 2022
•
By
Ayisha Sharma
Novo's Traditional Stronghold Has Been In Type 2 Diabetes • Source: Shutterstock
More from Earnings
More from Business